Philip Morris International (PM)
(Delayed Data from NYSE)
$125.62 USD
+0.97 (0.78%)
Updated Sep 13, 2024 04:00 PM ET
After-Market: $125.61 -0.01 (-0.01%) 7:58 PM ET
2-Buy of 5 2
D Value B Growth F Momentum D VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$125.62 USD
+0.97 (0.78%)
Updated Sep 13, 2024 04:00 PM ET
After-Market: $125.61 -0.01 (-0.01%) 7:58 PM ET
2-Buy of 5 2
D Value B Growth F Momentum D VGM
Zacks News
Why Is Philip Morris (PM) Up 3.6% Since Last Earnings Report?
by Zacks Equity Research
Philip Morris (PM) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Philip Morris Extends Deal With KT&G, RRPs Expansion on Track
by Zacks Equity Research
Philip Morris (PM) will start commercialization of KT&G's smoke-free alternatives outside South Korea, beginning with Russia.
Philip Morris Gains on RRPs & Pricing Amid Low Cigarette Sales
by Zacks Equity Research
Philip Morris' (PM) cigarette sales have been dismal due to lower demand and pandemic-led restrictions. Nevertheless, RRPs are depicting continued rise.
The Zacks Analyst Blog Highlights: Facebook, Verizon Communications, Pfizer, Novartis and Philip Morris International
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Facebook, Verizon Communications, Pfizer, Novartis and Philip Morris International
Top Research Reports for Facebook, Verizon & Pfizer
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including Facebook (FB), Verizon Communications (VZ) and Pfizer (PFE).
Will Staples ETFs Gain on Philip Morris' Q2 Earnings Beat?
by Sweta Jaiswal, FRM
Philip Morris delivers better-than-expected earnings results amid the coronavirus crisis.
Company News for Jul 22, 2020
by Zacks Equity Research
Companies In The News Are: PM, SYF, NVS, PACR.
How Will Philip Morris' Q2 Earnings Impact These Staples ETFs?
by Sweta Jaiswal, FRM
Philip Morris expects second-quarter 2020 results to reflect considerable impact of the coronavirus pandemic.
Philip Morris (PM) Q2 Earnings Beat Estimates, Decline Y/Y
by Zacks Equity Research
Philip Morris' (PM) second-quarter 2020 results reflect solid pricing variance. However, adverse volume/mix, mainly due to soft cigarette volumes, weighs on revenues and earnings.
Philip Morris (PM) Q2 Earnings and Revenues Top Estimates
by Zacks Equity Research
Philip Morris (PM) delivered earnings and revenue surprises of 18.35% and 2.45%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?
Factors You Must Watch Before Philip Morris (PM) Q2 Earnings
by Zacks Equity Research
Philip Morris' (PM) second-quarter 2020 results are likely to reflect adverse impacts of coronavirus. The company expects lower duty-free sales and a fall in the rate of new IQOS user acquisition.
The Zacks Analyst Blog Highlights: Comcast, Philip Morris International, Lockheed Martin, Chevron and American Express
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Comcast, Philip Morris International, Lockheed Martin, Chevron and American Express
Q2 Earnings Scorecard & Top Stock Reports for Comcast, Philip Morris & Lockheed Martin
by Sheraz Mian
We have a Q2 earnings season update, in addition to featuring fresh research reports on Comcast (CMCSA), Philip Morris International (PM) and Lockheed Martin (LMT) in today's Research Daily
Earnings Preview: Philip Morris (PM) Q2 Earnings Expected to Decline
by Zacks Equity Research
Philip Morris (PM) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Philip Morris' (PM) IQOS Gets FDA Nod to be Marketed as MRTP
by Zacks Equity Research
Philip Morris (PM) is likely to benefit from the FDA's latest move. Notably, the FDA authorizes IQOS's marketing as a modified risk tobacco product.
Phillip Morris Troubled by COVID-Related Woes & Pricing Aids
by Zacks Equity Research
Philip Morris (PM) anticipates coronavirus woes to have detrimental impacts on its second-quarter performance. Nonetheless, the company's pricing strength bodes well.
The Zacks Analyst Blog Highlights: Alphabet, AT&T, Philip Morris International, Amazon, Microsoft, Texas Instruments and United Parcel Service
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Alphabet, AT&T, Philip Morris International, Amazon, Microsoft, Texas Instruments and United Parcel Service
Top Stock Reports for Alphabet, AT&T & Philip Morris
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including Alphabet (GOOGL), AT&T (T) and Philip Morris International (PM).
Altria Focuses on Pricing & RRPs Amid Soft Cigarette Volumes
by Zacks Equity Research
Altria's (MO) focus on oral tobacco products along with solid pricing bodes well, though cigarette volumes have been soft due to rising health consciousness and government regulations.
Why Is Philip Morris (PM) Down 3.6% Since Last Earnings Report?
by Zacks Equity Research
Philip Morris (PM) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Tobacco Industry Outlook Smoking Hot on Pricing & RRP Focus
by Vrishali Bagree
Companies in the tobacco industry are likely to benefit from their efficient pricing strategy and focus on low-risk products amid receding cigarette volumes.
Inside the Q1 Earnings Strength of Staples ETFs and Q2 View
by Sanghamitra Saha
Staples stocks had a decent Q1 earnings season but will see negative currency translations in Q2. Plus, not all players in the sector are immune to coronavirus-led lockdowns.
Factors to Know Ahead of Archer Daniels' (ADM) Q1 Earnings
by Zacks Equity Research
Although Archer Daniels' (ADM) Q1 performance is likely to have gained from the nutrition unit, softness in the Ag Services and Oilseeds, and Carbohydrate Solutions units might have been a drag.
How Has Philip Morris' Q1 Earnings Beat Impacted Staples ETFs?
by Sweta Jaiswal, FRM
We highlight the impact of Philip Morris' Q1 earnings on ETFs with significant exposure to the company.
Philip Morris (PM) Beats Q1 Earnings and Revenue Estimates
by Zacks Equity Research
Philip Morris (PM) delivered earnings and revenue surprises of 7.08% and 6.18%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?